Please Wait...

OPG // Osteoprotegerin

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Osteoprotegerin (OPG) is a secretory glycoprotein composed of 401 amino acids (mature form with 380 amino acids) and seven structural domains. OPG exists as a disulfide-linked homodimer or as a monomer (Simonet et al., 1997). OPG belongs to the TNF receptor superfamily and was initially described as a cytokine, binding essentially the Receptor Activator of Nuclear Factor κβ Ligand (RANKL).Since, OPG have been found to be implicated in other pathways (Baud’huin et al., 2013). In addition to its implication in bone metabolism, OPG have been associated with diabetes of types 1 and 2, obesity metabolic syndrome, atherosclerosis and hypertension (Pérez de Ciriza et al., 2015).

Bioclinica Lab employs a manual sandwich immunoassay for the measurement of OPG in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (2 weeks ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (2 weeks ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (3 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (4 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (4 weeks ago)